Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Company

Abbott Laboratories

Tracked across 34 events · 498 articles · First seen Feb 01, 2025 · Last active Jul 06, 2026

Sentiment
7
Attention
6
Events
34
Relationships
30
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 -50
Regulatory
Impact: Abbott Laboratories, through its Abbott Diabetes Care division, is at the center of this event due to the recall of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors. The malfunction has led to serious injuries and deaths, negatively impacting the company's reputation and potentially its stock price.
Dec 03, 2025 · 6 articles
4 70
Business
Impact: Abbott Laboratories Limited has begun commercial supplies under its Rs. 825 crore CDMO mandate, marking a significant milestone in its transition toward long-duration global manufacturing partnerships and strengthening its manufacturing infrastructure.
Jul 01, 2026 · 6 articles
4 70
Business
Impact: As a major player in the CLIA market, Abbott Laboratories is strengthening its market position through innovation and strategic collaborations, with its ARCHITECT and Alinity i systems playing a major role in advancing high-throughput immunodiagnostic testing globally.
Jun 05, 2026 · 6 articles
4 60
Tech
Impact: Abbott Laboratories, Inc. is identified as a top company in the epigenetics market, indicating its presence and potential to benefit from market growth.
Jun 26, 2026 · 6 articles
2 20
Tech
Impact: Abbott Laboratories' Droplet Digital PCR technology is utilized in Biodesix's presentations and will co-present new data on MRD monitoring, indicating its role as a technology provider and collaborator.
Apr 06, 2026 · 6 articles
4 0
Business
Impact: Abbott Laboratories' FreeStyle Libre 2 Plus sensor is compatible with Insulet Corporation's Omnipod 5 in Spain, indicating a potential for increased sensor sales due to the new system's launch.
Jul 06, 2026 · 6 articles
6 5
Business
Impact: Abbott Laboratories is one of several Indian generic drugmakers poised to enter the market with lower-priced versions of semaglutide once Semaglutide loses patent exclusivity.
Nov 11, 2025 · 6 articles
4 10
Business
Impact: Abbott Laboratories is conducting preliminary core examination for the Bracken well, contributing to the analytic phase of Max Power Mining's exploration.
Apr 02, 2026 · 7 articles
4 10
Business
Impact: Abbott Laboratories provided assay and analytical data for the drill core samples, ensuring the quality and reliability of the reported results.
Apr 09, 2026 · 6 articles
4 50
Regulatory
Impact: Abbott Laboratories is a partner in Canadian Strategic Missions Corporation's Automated Manufacturing for Nuclear Micro-Reactors project, benefiting from the Next Generation Manufacturing Canada funding.
Apr 20, 2026 · 6 articles
6 0
Regulatory
Impact: Abbott Laboratories is mentioned in the context of a previous infant formula recall in 2022, which caused a national shortage, providing a comparison point for the current ByHeart recall.
Nov 09, 2025 · 33 articles
4 0
Business
Impact: Gautam Swaroop worked at Abbott Laboratories, where he scaled the emerging markets business, further building his expertise in business growth.
Jun 24, 2026 · 17 articles
2 0
Business
Impact: Abbott Laboratories acquired Cardiovascular Systems, a company previously led by Scott R. Ward, which is part of his extensive experience in the medical device industry.
May 19, 2026 · 6 articles
2 0
Business
Jan 08, 2026 · 6 articles
4 0
Business
Jan 05, 2026 · 14 articles
2 0
Business
Apr 02, 2026 · 6 articles
4 0
Business
Mar 30, 2026 · 8 articles
6 0
Business
Mar 20, 2026 · 8 articles
4 0
Business
Mar 17, 2026 · 7 articles
3 0
Regulatory
Apr 17, 2026 · 6 articles
4 0
Domestic
Apr 16, 2026 · 6 articles
4 0
International
Apr 16, 2026 · 14 articles
2 0
Business
Apr 13, 2026 · 6 articles
4 0
Business
Apr 10, 2026 · 6 articles
2 0
Domestic
May 16, 2026 · 6 articles
6 0
Domestic
May 04, 2026 · 58 articles
4 0
Business
May 15, 2026 · 6 articles
4 0
Business
May 08, 2026 · 7 articles
6 0
Domestic
May 08, 2026 · 114 articles
4 0
Regulatory
May 04, 2026 · 6 articles
+ 4 more events View on Dashboard
Astec LifeSciences unrelated Abbott Laboratories Abbott Laboratories does not have a direct business relationship with Astec Life
Astec LifeSciences unrelated Abbott Laboratories Astec LifeSciences does not have a direct business relationship with Abbott Labo
Sun Pharma competitor Abbott Laboratories Abbott Laboratories competes directly with Sun Pharma in the global pharmaceutic
Sun Pharma competitor Abbott Laboratories Sun Pharmaceutical Industries acts as a major competitor to Abbott Laboratories
GenBioPro Abbott Laboratories
GenBioPro Abbott Laboratories
Kyle Duncan (judge) Abbott Laboratories
Kyle Duncan (judge) Abbott Laboratories
Cosmos Health Abbott Laboratories
Cosmos Health Abbott Laboratories
Liz Murrill Abbott Laboratories
Liz Murrill Abbott Laboratories
Greg Siokas Abbott Laboratories
Greg Siokas Abbott Laboratories
Joe Biden Abbott Laboratories
Joe Biden Abbott Laboratories
India Abbott Laboratories
India Abbott Laboratories
United States Abbott Laboratories
United States Abbott Laboratories
Donald Trump Abbott Laboratories
Donald Trump Abbott Laboratories
ERGEN INTELLIGENCE
Track Abbott Laboratories live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.